|Articles|August 23, 2019
CRISPR-edited EML4-ALK Isogenic Cell Line
Author(s)ATCC
Cancer researchers are challenged by the lack of precise disease models. Genome editing was used to create an isogenic lung cancer cell line that was tested for drug sensitivity.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
PharmTech Weekly Roundup - February 6, 2026
5